Health Cingulate Completes First Cohort of Phase 3 Adult Onset and Duration Trial of CTx-1301… Jason Junior Apr 4, 2023 <!-- Name:DistributionId Value:8801286 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value: -->…
Health KemPharm Announces U.S. Launch of Innovative ADHD Treatment AZSTARYS™ (serdexmethylphenidate and… Jason Junior Jul 21, 2021 CELEBRATION, Fla., July 21, 2021 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, today announced the U.S. commercial launch of…